Proprietary lactic acid bacteria from Maypro achieves Non-GMO Project Verification

July 5, 2019

Maypro Group has announced that its proprietary strain of Lactobacillus acidophilus, L-92, is the first ingredient in its portfolio become Non-GMO Project Verified.

Maypro Group (Purchase, NY) has announced that its proprietary strain of Lactobacillus acidophilus, L-92, is the first ingredient in its portfolio become Non-GMO Project Verified.

“We are really excited to have one of our ingredients become part of the Non-GMO Project Verified portfolio” said Steve Yamada, Maypro Group’s founder and chairman, in a press release. “We hope that we can continue verifying our line of ingredients.”

L-92 is supported by five published double-blind placebo-controlled human clinical studies in both children and adults, and shows promise as a medical food, shown in human clinical studies to help with the dietary management of patients with psoriasis, allergic rhinitis, and cedar pollinosis. These studies have shown that L-92 may soothe and calm irritated skin, reduce redness and swelling, as well as reduce seasonal discomforts.